دورية أكاديمية
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.
العنوان: | Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. |
---|---|
المؤلفون: | Lipson, D. A. inc., Halpin, David M |
بيانات النشر: | NEJM |
سنة النشر: | 2018 |
المجموعة: | RD&E Research Repository (Royal Devon and Exeter NHS Foundation Trust) |
مصطلحات موضوعية: | Wessex Classification Subject Headings::Respiratory medicine, Administration, Inhalation, Adrenergic beta-Agonists, Adult, Aged, Androstadienes, Benzyl Alcohols, Bronchodilator Agents, Chlorobenzenes, Double-Blind Method, Drug Administration Schedule, Drug Combinations, Dyspnea, Female, Glucocorticoids, Hospitalization, Humans, Intention to Treat Analysis, Male, Middle Aged, Muscarinic Antagonists, Pulmonary Disease, Chronic Obstructive, Quality of Life, Quinuclidines |
الوصف: | The benefits of triple therapy for chronic obstructive pulmonary disease (COPD) with an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA), as compared with dual therapy (either inhaled glucocorticoid-LABA or LAMA-LABA), are uncertain. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
تدمد: | 1533-4406 29668352 |
العلاقة: | Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. 2018, 378 (18):1671-1680 N. Engl. J. Med.; http://hdl.handle.net/11287/620707Test; The New England journal of medicine |
DOI: | 10.1056/NEJMoa1713901 |
الإتاحة: | https://doi.org/10.1056/NEJMoa1713901Test http://hdl.handle.net/11287/620707Test |
حقوق: | Archived with thanks to The New England journal of medicine |
رقم الانضمام: | edsbas.985A9F66 |
قاعدة البيانات: | BASE |
ResultId |
1 |
---|---|
Header |
edsbas BASE edsbas.985A9F66 821 3 Academic Journal academicJournal 821.334289550781 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.985A9F66&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doi.org/10.1056/NEJMoa1713901# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Lipson%2C+D%2E+A%2E+inc%2E%22">Lipson, D. A. inc.</searchLink><br /><searchLink fieldCode="AR" term="%22Halpin%2C+David+M%22">Halpin, David M</searchLink> ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => NEJM ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2018 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => RD&E Research Repository (Royal Devon and Exeter NHS Foundation Trust) ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Wessex+Classification+Subject+Headings%3A%3ARespiratory+medicine%22">Wessex Classification Subject Headings::Respiratory medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Administration%22">Administration</searchLink><br /><searchLink fieldCode="DE" term="%22Inhalation%22">Inhalation</searchLink><br /><searchLink fieldCode="DE" term="%22Adrenergic+beta-Agonists%22">Adrenergic beta-Agonists</searchLink><br /><searchLink fieldCode="DE" term="%22Adult%22">Adult</searchLink><br /><searchLink fieldCode="DE" term="%22Aged%22">Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Androstadienes%22">Androstadienes</searchLink><br /><searchLink fieldCode="DE" term="%22Benzyl+Alcohols%22">Benzyl Alcohols</searchLink><br /><searchLink fieldCode="DE" term="%22Bronchodilator+Agents%22">Bronchodilator Agents</searchLink><br /><searchLink fieldCode="DE" term="%22Chlorobenzenes%22">Chlorobenzenes</searchLink><br /><searchLink fieldCode="DE" term="%22Double-Blind+Method%22">Double-Blind Method</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+Administration+Schedule%22">Drug Administration Schedule</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+Combinations%22">Drug Combinations</searchLink><br /><searchLink fieldCode="DE" term="%22Dyspnea%22">Dyspnea</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22Glucocorticoids%22">Glucocorticoids</searchLink><br /><searchLink fieldCode="DE" term="%22Hospitalization%22">Hospitalization</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Intention+to+Treat+Analysis%22">Intention to Treat Analysis</searchLink><br /><searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Muscarinic+Antagonists%22">Muscarinic Antagonists</searchLink><br /><searchLink fieldCode="DE" term="%22Pulmonary+Disease%22">Pulmonary Disease</searchLink><br /><searchLink fieldCode="DE" term="%22Chronic+Obstructive%22">Chronic Obstructive</searchLink><br /><searchLink fieldCode="DE" term="%22Quality+of+Life%22">Quality of Life</searchLink><br /><searchLink fieldCode="DE" term="%22Quinuclidines%22">Quinuclidines</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => The benefits of triple therapy for chronic obstructive pulmonary disease (COPD) with an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA), as compared with dual therapy (either inhaled glucocorticoid-LABA or LAMA-LABA), are uncertain. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1533-4406<br />29668352 ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. 2018, 378 (18):1671-1680 N. Engl. J. Med.; http://hdl.handle.net/11287/620707; The New England journal of medicine ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1056/NEJMoa1713901 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1056/NEJMoa1713901<br />http://hdl.handle.net/11287/620707 ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => Archived with thanks to The New England journal of medicine ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.985A9F66 ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1056/NEJMoa1713901
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Wessex Classification Subject Headings::Respiratory medicine
[Type] => general
)
[1] => Array
(
[SubjectFull] => Administration
[Type] => general
)
[2] => Array
(
[SubjectFull] => Inhalation
[Type] => general
)
[3] => Array
(
[SubjectFull] => Adrenergic beta-Agonists
[Type] => general
)
[4] => Array
(
[SubjectFull] => Adult
[Type] => general
)
[5] => Array
(
[SubjectFull] => Aged
[Type] => general
)
[6] => Array
(
[SubjectFull] => Androstadienes
[Type] => general
)
[7] => Array
(
[SubjectFull] => Benzyl Alcohols
[Type] => general
)
[8] => Array
(
[SubjectFull] => Bronchodilator Agents
[Type] => general
)
[9] => Array
(
[SubjectFull] => Chlorobenzenes
[Type] => general
)
[10] => Array
(
[SubjectFull] => Double-Blind Method
[Type] => general
)
[11] => Array
(
[SubjectFull] => Drug Administration Schedule
[Type] => general
)
[12] => Array
(
[SubjectFull] => Drug Combinations
[Type] => general
)
[13] => Array
(
[SubjectFull] => Dyspnea
[Type] => general
)
[14] => Array
(
[SubjectFull] => Female
[Type] => general
)
[15] => Array
(
[SubjectFull] => Glucocorticoids
[Type] => general
)
[16] => Array
(
[SubjectFull] => Hospitalization
[Type] => general
)
[17] => Array
(
[SubjectFull] => Humans
[Type] => general
)
[18] => Array
(
[SubjectFull] => Intention to Treat Analysis
[Type] => general
)
[19] => Array
(
[SubjectFull] => Male
[Type] => general
)
[20] => Array
(
[SubjectFull] => Middle Aged
[Type] => general
)
[21] => Array
(
[SubjectFull] => Muscarinic Antagonists
[Type] => general
)
[22] => Array
(
[SubjectFull] => Pulmonary Disease
[Type] => general
)
[23] => Array
(
[SubjectFull] => Chronic Obstructive
[Type] => general
)
[24] => Array
(
[SubjectFull] => Quality of Life
[Type] => general
)
[25] => Array
(
[SubjectFull] => Quinuclidines
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Lipson, D. A. inc.
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Halpin, David M
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2018
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 15334406
)
[1] => Array
(
[Type] => issn-print
[Value] => 29668352
)
[2] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
)
)
)
)
)
)
|
IllustrationInfo |